Achieve Life Sciences, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Achieve Life Sciences, Inc. (ACHV) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $3.65 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2014-03-31 was $3.00, a 0.00% change year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2013-03-31 was $3.00.
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $2.69, a 10.33% decline from fiscal 2014.
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2014 was $3.00, a 0.00% change from fiscal 2013.
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $3.00, a 23.86% decline from fiscal 2012.
- Achieve Life Sciences, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2012 was $3.94, a 1.55% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.65 10-Q · filed 2026-08-11 | |||
| 2015-12-31 | $2.69 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $3.00 10-K · filed 2017-02-23 | |||
| 2014-09-30 | $3.00 10-Q · filed 2014-10-30 | |||
| 2014-06-30 | $3.00 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | $3.00 10-Q · filed 2014-04-30 | |||
| 2013-12-31 | $3.00 10-K · filed 2016-03-09 | |||
| 2013-09-30 | $3.00 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | $3.00 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $3.00 10-Q · filed 2013-05-02 | |||
| 2012-12-31 | $3.94 10-K · filed 2015-03-26 | |||
| 2012-09-30 | $3.94 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | $3.36 10-Q · filed 2012-08-02 | |||
| 2011-12-31 | $3.88 10-K · filed 2014-03-11 | |||
| 2010-12-31 | $4.22 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |